Available Programs

The Evolution of Antibody–Drug Conjugates in Breast Cancer

Register now for this live, CME-certified Webinar, featuring a discussion of the growing role of antibody–drug conjugates in the management of patients with breast cancer by renowned clinical experts.

During the live Webinar, you will have many opportunities to interact with the faculty through interactive patient case scenarios illustrating key clinical issues and dynamic panel discussions.

1 upcoming events, beginning 10/02/2020More Information

NSCLC Biomarkers: Expert Insights on New Targets, Testing Options, and Personalized Treatment

Join us for this interactive, live-stream Webinar featuring a pathologist and medical oncologist to gain expert insights on testing for new and emerging predictive biomarkers for precision medicine in advanced NSCLC.

This is not an official event of CAP20 and is not sponsored, endorsed, or accredited by the CAP or any of the cosponsoring organizations of CAP20.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 10/13/2020More Information

COVID-19: Implications for Patients With CLL

Gain expert opinion on the intersection of the COVID-19 pandemic and CLL treatment shortly after new findings are made available, through a series of expert commentaries and a live Webinar, plus downloadable slides.

1 upcoming events, beginning 10/15/2020More Information

The New Biomarkers Clinicians Need to Know for Precision Therapy in Lung Cancer

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 10/17/2020More Information

Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma

Register now for this live, CME -certified symposium, featuring expert discussion of current status and future directions for immunotherapy in hepatocellular carcinoma.

During the live symposium, you will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Thank you for your interest in attending this the Clinical Care Options’ (CCO) symposium, “Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma”, this that was originally scheduled as an in-person symposium in Madrid, Spain. Due to the global impact of COVID-19, ESMO organizers have decided to host the ESMO Annual Meeting in a virtual format.

As such, this live symposium will also now be held as a virtual live Webinar. Please note that the Webinar will still feature the original expert faculty, interactivity, evidence-based content, and panel discussions as the in-person symposium. When participating in the live Webinar, you will be able to text questions directly to the faculty and the planned agenda allows time for the faculty to discuss and answer submitted questions.

To register, click one of the links below and once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Thank you,
CCO Member Services

1 upcoming events, beginning 10/19/2020More Information

Optimizing Care in Lung Cancer: Current and Emerging Biomarkers for Immuno-Oncology

Join us for an exciting live webinar held during ASTRO’s 62nd Annual Meeting. Experts, Jamie E. Chaft, MD and  Kristin Higgins, MD discuss interdisciplinary approaches for optimizing the use of immune checkpoint inhibitor therapy for treating patients with lung cancer with a focus on how IO biomarkers can help guide treatment decisions and how radiotherapy interfaces with IO-based treatment approaches.

The American Society for Radiation Oncology (ASTRO) has reviewed and approved this symposium as appropriate for presentation as an Industry Satellite Symposium. The symposium constitutes the content and views of the provider and is not part of the official ASTRO Annual Meeting program.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 10/25/2020More Information

HER2, HER3, and TROP2: Diagnostic Testing and Treatment Implications in Breast, GI, and Lung Cancers

Join us for this ongoing Webinar series, in which experts discuss best practices in biomarker testing for HER2, HER3, and TROP2 in metastatic breast, gastrointestinal, and lung cancers and examine evidence on how current and emerging therapeutics targeting these biomarkers might be optimally used.

1 upcoming events, beginning 10/29/2020More Information

AML: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm

Friday Satellite Symposium on Acute Myeloid Leukemia: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Application of Individualized Treatment for CLL: Novel Agents, Combinations, and Sequencing Therapy

Friday Satellite Symposium on Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Accelerating Toward a Myeloma Cure: Emerging Data, New Agents, and an Evolving Treatment Paradigm

Friday Satellite Symposium on Accelerating Toward a Cure for Myeloma: Emerging Data, New Agents, and an Evolving Treatment Paradigm, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Advances in GvHD: Current Treatments, Optimizing Prophylaxis, and Integrating Novel Therapies

Friday Satellite Symposium on Advances in GvHD: Expert Guidance on the Current Treatment Landscape, Optimizing Prophylaxis, and Integrating Novel Therapies, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Clinical Advances in Immune Thrombocytopenia: Integrating New Therapies

Friday Satellite Symposium on Clinical Advances in Immune Thrombocytopenia: Integrating New Therapies, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms

Friday Satellite Symposium on A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes

Friday Satellite Symposium on Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Contemporary Management of Hemophilia A: Expert Guidance to Improve Patient Outcomes

Friday Satellite Symposium on Contemporary Management of Hemophilia A: Expert Guidance to Improve Patient Outcomes, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

New Agents and Therapeutic Strategies in β-Thalassemia

Friday Satellite Symposium on New Agents and Therapeutic Strategies in β-Thalassemia, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Transforming the Treatment Paradigm for Patients With MDS

Friday Satellite Symposium on Transforming the Treatment Paradigm for Patients With MDS, preceding the 62nd ASH Annual Meeting and Exposition.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

1 upcoming events, beginning 12/04/2020More Information

Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types

Thank you for your interest in attending this Clinical Care Options’ (CCO) symposium, Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types, this was originally scheduled as an in-person symposium in Chicago, Illinois. Due to the global impact of COVID-19, ASCO organizers have decided to host the ASCO Annual Meeting in a virtual format.

As such, this live symposium will also now be held as virtual live Webinars. Please note that the Webinar will still feature the original expert faculty, interactivity, evidence-based content, and panel discussions as the in-person symposium. When participating in the live Webinar, you will be able to text questions directly to the faculty and the planned agenda allows time for the faculty to discuss and answer submitted questions.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Thank you,
CCO Member Services

There are no upcoming events, please check back soon.

COVID19: Ensuring the Quality, Resiliency, and Continuity of Breast Cancer Care During a Pandemic

Gain insights on how the COVID-19 pandemic is impacting breast cancer care along with expert input on treatment considerations to optimize management while limiting risk of exposure as new data emerge in this live Webinar, plus downloadable slides.

There are no upcoming events, please check back soon.

Current and Future Immunotherapy Approaches for HCC: Evidence, Guidance, and Resources

Interact with experts during a 1-hour, CME/CE-certified live meeting examining recent advances and current best practices in the use of immune checkpoint inhibitors for treating hepatocellular carcinoma. This program will specifically focus on educating hepatologists, medical oncologists, and other members of the multidisciplinary care team. Register today!

There are no upcoming events, please check back soon.

Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Join us for this dynamic, IME live Webinar where pancreatic cancer experts will provide a global view on BRCA mutations, PARP inhibitors and biomarker-driven treatment strategies in pancreatic cancer; including patient case discussions and discussion of new data.

Sign up now!

Thank you for your interest in attending the Clinical Care Options (CCO) live Webinar, “Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer.”

This live Webinar will feature expert faculty, and provide interactivity, evidence-based content, and panel discussions. When participating in a live Webinar, you will be able to text questions directly to the faculty and the planned agenda allows time for the faculty to discuss and answer submitted questions.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Thank you,

CCO Member Services

There are no upcoming events, please check back soon.

Insights Into Sequencing Treatment and Overcoming Resistance in HR-Positive/HER2-Negative ABC

Thank you for your interest in attending the Clinical Care Options’ (CCO) symposium, “Insights Into Sequencing Treatment and Overcoming Resistance in HR-Positive/HER2-Negative ABC” that was originally scheduled as an in-person symposium in Chicago, Illinois. Due to the global impact of COVID-19, ASCO organizers have decided to host the ASCO Annual Meeting in a virtual format.

As such, this live symposium will also now be held as virtual live Webinars. Please note that each Webinar will still feature the original expert faculty, interactivity, evidence-based content, and panel discussions as the in-person symposium. When participating in a live Webinar, you will be able to text questions directly to the faculty and the planned agenda allows time for the faculty to discuss and answer submitted questions.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Thank you,
CCO Member Services

There are no upcoming events, please check back soon.

New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance

Join us for this virtual, live-stream Webinar hosted by the National Comprehensive Cancer Network in partnership with Clinical Care Options to learn more about how experts are managing their patients with urothelial carcinoma. This expert panel will address current clinical challenges with patient case examples, highlight novel studies in urothelial carcinoma, and answer audience questions during the live event.

Thank you for your interest in attending the Clinical Care Options’ (CCO) symposium, “New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance” that was originally scheduled as an in-person symposium in Chicago, Illinois. Due to the global impact of COVID-19, ASCO organizers have decided to host the ASCO Annual Meeting in a virtual format.

As such, this live symposium will also now be held as a virtual live Webinar. Please note that the Webinar will still feature the original expert faculty, interactivity, evidence-based content, and panel discussions as the in-person symposium. When participating in the live Webinar, you will be able to text questions directly to the faculty and the planned agenda allows time for the faculty to discuss and answer submitted questions.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Thank you,
CCO Member Services

There are no upcoming events, please check back soon.

New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance

Join us for this virtual, live-stream Webinar hosted by the National Comprehensive Cancer Network in partnership with Clinical Care Options to learn more about how experts are managing their patients with urothelial carcinoma. This expert panel will address current clinical challenges with patient case examples, highlight novel studies in urothelial carcinoma, and answer audience questions during the live event.

This symposium is sponsored by NCCN in partnership with Clinical Care Options, LLC. This is not an official program of the American Association for Cancer Research Annual Meeting.

There are no upcoming events, please check back soon.

NSCLC Biomarkers: Current Landscape and Future Perspectives for Precision Medicine

Join us for this interactive, live-stream Webinar featuring a pathologist and medical oncologist to get up to date on new and emerging biomarkers for personalized therapy in lung cancer, including a review of the latest clinical data, key strategies for optimal biomarker detection, and communication among the multidisciplinary team.

Register now!

This live webinar is independent and not part of the official American Society for Clinical Pathology 2020 accredited continuing medical education (CME) virtual annual meeting education program.

To Register: On the Event Dates page, click a date/time, then click the blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

There are no upcoming events, please check back soon.

Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors

Join us for this dynamic, IME live Webinar where ovarian cancer experts will provide a global view on PARP inhibitors and biomarker-driven treatment strategies in ovarian cancer; including patient case discussions and discussion of new data.

Sign up now!

Thank you for your interest in attending the Clinical Care Options (CCO) live Webinar, “Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors.”

This live Webinar will feature expert faculty, and provide interactivity, evidence-based content, and panel discussions. When participating in a live Webinar, you will be able to text questions directly to the faculty and the planned agenda allows time for the faculty to discuss and answer submitted questions.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Thank you,
CCO Member Services

There are no upcoming events, please check back soon.

Honing Treatment Strategies in Advanced Prostate Cancer: Latest Evidence to Guide Clinical Practice

Interact with an expert during this 1-hour, CME/CE/CPE-certified live meeting focused on current best practices for managing advanced prostate cancer including hormone-sensitive metastatic disease, non-metastatic and metastatic CRPC.

2 upcoming events, beginning 10/08/2020More Information

Optimizing Multiple Myeloma Care: Expert Guidance for the Practicing Clinician

Join us for a live CME/CE/CPE-certified event to hear from experts on the latest data and therapeutic options for patients with myeloma.

2 upcoming events, beginning 10/09/2020More Information

Advances to Improve Clinical Outcomes and Quality of Life for Veterans With Multiple Myeloma

Join us for a live CME/CE/CPE-certified event to hear from experts on the latest data and therapeutic options for patients with myeloma.

There are no upcoming events, please check back soon.

BTK Inhibition Strategies in B-Cell Malignancies: Expert Perspectives to Guide Clinical Decisions

Register now to hear expert insights on the optimal treatment of B-cell malignancies with BTK inhibitors in this interactive, case-based 1-hour live meeting. After the meeting, download the associated slideset for use in your clinic.

There are no upcoming events, please check back soon.

Critical Advances in CLL: Building on Recent Progress for Community Practices

Join us online for a live 1-hour CME/CE/CPE-certified expert-led workshop on the optimal management of patients with treatment-naive and relapsed/refractory chronic lymphocytic leukemia.

There are no upcoming events, please check back soon.

Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Interact with an expert during this 1-hour, CME-certified live meeting examining recent advances and current best practices in the use of immune checkpoint inhibitors for treating gastroesophageal cancers. Register today!

There are no upcoming events, please check back soon.

Moving The Treatment of MPNs Forward: Integration of Recent Data Sets Into Clinical Practice

Interact with an expert during this 1-hour, CME/CE/CPE-certified, live meeting examining recent advances and current best practices in managing patients with myeloproliferative neoplasms. This will include discussions of current recommendations and strategies to support physician collaboration and timely patient referral.

Register today!

There are no upcoming events, please check back soon.